NCT04471298View on ClinicalTrials.gov

A Study of Qishenyiqi Dripping Pills in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Healthy Participants
Interventions
DRUG

Qishenyiqi dripping pills, 6 bags

28 consecutive days

DRUG

Qishenyiqi dripping pills, 9 bags

28 consecutive days

DRUG

Qishenyiqi dripping pills, 12 bags

28 consecutive days

DRUG

Qishenyiqi dripping pills placebo, 6 bags

28 consecutive days

DRUG

Qishenyiqi dripping pills placebo, 9 bags

28 consecutive days

DRUG

Qishenyiqi dripping pills placebo, 12 bags

28 consecutive days

Trial Locations (1)

Unknown

The First Teaching Hospital of Tianjin University of TCM, Tianjin

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY

NCT04471298 - A Study of Qishenyiqi Dripping Pills in Healthy Participants | Biotech Hunter | Biotech Hunter